Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19

Hao-Ting Hsu; Ni-Chun Kuo; Po-Yen Chen; Sheng-Ling Jan

doi:10.3389/fped.2023.1180534

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19

Front Pediatr. 2023 Jun 27:11:1180534. doi: 10.3389/fped.2023.1180534. eCollection 2023.

Authors

Hao-Ting Hsu¹, Ni-Chun Kuo¹, Po-Yen Chen¹, Sheng-Ling Jan^{2

3

4}

Affiliations

¹ Department of Pediatrics, Children's Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan.
² Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
³ Department of Pediatrics, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
⁴ Department of Pediatrics, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Abstract

Fulminant myocarditis in children was rare during the coronavirus disease 2019 pandemic, but it had the potential for high morbidity and mortality. We describe the clinical course of a previously healthy 9-month-old young male infant who rapidly deteriorated into cardiogenic shock due to coronavirus disease 2019-related fulminant myocarditis. He developed severe heart failure and multiple organ dysfunction syndrome that were treated promptly with central venoarterial extracorporeal membrane oxygenation and continuous venovenous hemofiltration. He made a good recovery without significant morbidity.

Keywords: COVID-19; VA-ECMO; coronavirus disease 2019; fulminant myocarditis; myocarditis; pediatric.

Publication types

Case Reports